Effects of Manual Lymphatic Drainage in the Neck in Healthy Subjects. Experimental Randomized Crossover Study

Effects of Different Manoeuvres of Manual Lymphatic Drainage in the Neck on Systems Nervous, Cardiovascular, Respiratory and Lymphatic in Healthy Subjects. Experimental Randomized Crossover Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03709407

Enrollment

Registered

2018-10-17

Start date

2018-06-01

Completion date

2020-03-19

Last updated

2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Heart Rate Low, Lymphatic Diseases, Nervous System Diseases, Sympathetic

Brief summary

Drainage manoeuvres described in different Manual Lymphatic Drainage methods, suggest modificactions in vital signs, by changes at nervous system, that would involve modifications to heart rate, breathing rate, blood pressure, cardiac vascular level (arteries and lymphatics). In addition this hypothetical relaxing effect could be beneficial for other types of pathologies associated with the presence of stress, cardiac problems, respiratory pathology, muscle tension, muscle trigger points, etc. With this study investigators compare different manoeuvres in the neck area to observe the results in the participants regarding the basal state.

Detailed description

Differentes drainage manoeuvres suggest changes at nervous system (sympathetic and parasympathetic nervous system) and other vital constants

Interventions

OTHERcervical stimuli

Manouvres Godoy

OTHERterminus

Manouvres Vodder

OTHERPlacebo

placebo manouvre

OTHERControl group

lie down

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy men and women, physiotherapy students, to accept voluntarily participate and sign informed consent

Exclusion criteria

* systemic diseases, trauma history, neurological diseases, subjects with chronic pain, cardiovascular history of importance, depression, individuals who know the technique of MLD or that are under any medical treatment.

Design outcomes

Primary

Measure	Time frame	Description
Blood pressure	8 times for 4 weeks	Measured by validated tensiometer.

Secondary

Measure	Time frame	Description
range of movement	8 times for 4 weeks	Measured by validated goniometer CROM. 2 times for 4 weeks
pain pressure threshold	8 times for 4 weeks	Measured by validated analogical algometer
Respiratory rate	8 times for 4 weeks	Measured by observation
oxygen saturation	8 times for 4 weeks	Measured by validated pulseoximeter
Heart rate	8 times for 4 weeks	Measured by validated tensiometer and pulseoximeter

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026